Hyper Corporation Inc.

Equities

A065650

KR7065650004

Computer Hardware

End-of-day quote Korea S.E. 06:00:00 2024-05-09 pm EDT 5-day change 1st Jan Change
1,510 KRW -0.07% Intraday chart for Hyper Corporation Inc. +2.10% +53.61%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Medifron DBT Co., Ltd. announced that it has received KRW 20.999999826 billion in funding from FSN Co., Ltd. CI
Medifron DBT Co., Ltd. agreed to acquire 31.8% stake in Fingerlabs Co., Ltd. from FSN Co., Ltd.. CI
AdQUA Interactive Inc. agreed to acquire 48% stake in Emotion Global, Inc. from Medifron DBT Co., Ltd. for KRW 5.9 billion. CI
Medifron DBT Co., Ltd. agreed to acquire 19.49% stake in Makeus Co.,Ltd. from FSN Co., Ltd. for KRW 7.9 billion. CI
FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment completed the acquisition of a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd. CI
EN Creative Co., Ltd. agreed to acquire HMR business of Medifron DBT Co., Ltd. for KRW 5.7 billion CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 41.999999652 billion in funding CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 20.999999826 billion in funding from FSN Co., Ltd. CI
Medifron DBT Co., Ltd. announced that it has received KRW 4.0000092 billion in funding from T Scientific Co.,Ltd CI
Medifron DBT Co., Ltd.(KOSDAQ:A065650) dropped from S&P Global BMI Index CI
Medifron DBT Co., Ltd. announced that it has received KRW 3 billion in funding CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 3 billion in funding CI
Medifron DBT Co., Ltd. announced that it has received KRW 5 billion in funding from Shinhan Financial Investment Co., Ltd., Mirae Asset Securities Co. Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd. CI
Medifron DBT to Raise $3.9 Million via Stock Offering MT
Medifron DBT to Raise $10 Million via Stock Offering MT
Medifron DBT Co., Ltd. announced that it expects to receive KRW 5 billion in funding from Shinhan Financial Investment Co., Ltd., Mirae Asset Securities Co. Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd. CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 12.9999915 billion in funding from Best Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd., Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd. and other investors CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 4.9999995 billion in funding from T Scientific Co.,Ltd CI
Medifron DBT Co., Ltd. announced that it has received KRW 4 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 4 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm CI
Medifron DBT Co., Ltd. announced that it has received KRW 14.99999874 billion in funding from T Scientific Co., Ltd. CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 14.99999874 billion in funding from T Scientific Co., Ltd. CI
Medifron DBT Co., Ltd. announced that it has received KRW 8 billion in funding CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 8 billion in funding CI
J&Giant Spice Private Equity Partnership agreed to acquire SJ CORE CO.,LTD from Medifron DBT Co., Ltd. for KRW 22 billion. CI
Chart Hyper Corporation Inc.
More charts
Hyper Corporation Inc, formerly Medifron DBT Co Ltd, is a Korea-based company primarily engaged in the manufacture and sale of information and communication devices. The Company operates through three segments. The Information and Communication Technology Business segment is engaged in the manufacture and sale of gaming mice, gaming monitors, televisions, routers, and gaming devices. The Home Meal Replacement segment is engaged in the manufacture and supply of convenient meals. The New Drug Business segment is engaged in the development and sales of Alzheimer's treatments, non-narcotic painkillers, and early diagnosis kits for dementia.
More about the company
  1. Stock Market
  2. Equities
  3. A065650 Stock
  4. News Hyper Corporation Inc.
  5. Medifron DBT to Raise $3.9 Million via Stock Offering
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW